A new breast implant allows more patients to safely receive accelerated partial-breast irradiation than balloon brachytherapy or 3D conformal radiation, a study finds.
A new breast implant allows more patients to safely receive accelerated partial-breast irradiation than balloon brachytherapy or 3D conformal radiation, a study finds. The Strut Adjusted Volume Implant (SAVI) enables maximized dose to the target tissue and minimized dose to normal tissue.
Women with small breasts and/or inadequate skin and chest wall spacing face unacceptable toxicity with available accelerated partial-breast irradiation. SAVI is a multichannel, single-entry brachytherapy device designed to overcome that limitation.
After a median follow-up of two years, the researchers found overall dosimetry was outstanding. The median percentage of target volume receiving 90% of the prescription dose was 95.9%. (Int J Radiation Oncology Biol Phys doi:10.1016/j.ijrobp.2010.02.018).
“After almost two years, the patients showed the treatment was well-tolerated without significant side effects. To date, the control rate of cancer is also very promising,” said Dr. Catheryn Yashar, an associate professor of radiation oncology at the University of California, San Diego.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.